Stay updated with breaking news from Payload Modification Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of...
WuXi XDC and IntoCell signed MOU for a partnership in drug-linker technology and CRDMO services covering right from discovery to commercialisation.
/PRNewswire/ -- IntoCell today announced the signing of a Material Transfer Agreement (MTA) with option to license with ADC Therapeutics SA (NYSE: ADCT). Under...
London-based deal experts are the advisors for this collaboration and the ongoing partnering efforts for IntoCell's platform technologies and its lead programme, B7-H3 ADC. LONDON, Jan.
/PRNewswire/ -- PharmaVentures is pleased to announce that it acted as the lead advisor to IntoCell on its new research collaboration with Ab Studio. This...